Menu
Back to Journals » Vascular Health and Risk Management » Volume 14
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1475)
- Volume 19, 2023 (65)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 14, 2018
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
Skelley JW, Carter BS, Roberts MZ
Vascular Health and Risk Management 2018, 14:419-428
Published Date: 7 December 2018
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Hines DM, Rane P, Patel J, Harrison DJ, Wade RL
Vascular Health and Risk Management 2018, 14:409-418
Published Date: 10 December 2018
Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: a cross-sectional hospital-based study
Kamdem F, Mapoure Y, Hamadou B, Souksouna F, Doualla MS, Jingi AM, Kenmegne C, Kemta Lekpa F, Kweban Fenkeu J, Imandy G, Nda Mefo’o JP, Luma H
Vascular Health and Risk Management 2018, 14:401-408
Published Date: 6 December 2018
Enhanced external counterpulsation in rehabilitation of erectile dysfunction: a narrative literature review
Raeissadat SA, Javadi A, Allameh F
Vascular Health and Risk Management 2018, 14:393-399
Published Date: 3 December 2018
All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R
Vascular Health and Risk Management 2018, 14:383-392
Published Date: 20 November 2018
Noncardiac Lebanese hospitalized adult patients’ awareness of their coronary artery disease risk factors
Ghaddar F, Salameh P, Saleh N, Farhat F, Chahine R, Lahoud N, Hleyhel M, Zeidan RK
Vascular Health and Risk Management 2018, 14:371-382
Published Date: 8 November 2018
Walking activity during ambulant cardiac rehabilitation is related to maximum working capacity, age, and smoking behavior
Al Najem S, Groll A, Schmermund A, Nowak B, Voigtländer T, Kaltenbach U, Dohmann P, Andresen D, Scharhag J
Vascular Health and Risk Management 2018, 14:361-369
Published Date: 9 November 2018
Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
Bussotti M, Sommaruga M
Vascular Health and Risk Management 2018, 14:349-360
Published Date: 8 November 2018
Brachial–ankle pulse wave velocity, cardio-ankle vascular index, and prognosis
Ato D
Vascular Health and Risk Management 2018, 14:321-348
Published Date: 24 October 2018
Use of photoplethysmography to predict mortality in intensive care units
Kock KS, Marques JLB
Vascular Health and Risk Management 2018, 14:311-320
Published Date: 31 October 2018
Assessment of some traditional cardiovascular risk factors in medical doctors in Southern Nigeria
Ambakederemo TE, Chikezie EU
Vascular Health and Risk Management 2018, 14:299-309
Published Date: 24 October 2018
Redefined clinical spectra of diabetic foot syndrome
Shatnawi NJ, Al-Zoubi NA, Hawamdeh H, Khader YS, Omari AEK, Khammash MR
Vascular Health and Risk Management 2018, 14:291-298
Published Date: 18 October 2018
Role of androgens in cardiovascular pathology
Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN
Vascular Health and Risk Management 2018, 14:283-290
Published Date: 15 October 2018
Idiopathic true aneurysm of distal radial artery: case report
Al-Zoubi NA
Vascular Health and Risk Management 2018, 14:279-281
Published Date: 11 October 2018
Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)
Radchenko GD, Mushtenko LO, Sirenko YM
Vascular Health and Risk Management 2018, 14:265-278
Published Date: 11 October 2018
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
Correale M, Ferraretti A, Monaco I, Grazioli D, Di Biase M, Brunetti ND
Vascular Health and Risk Management 2018, 14:253-264
Published Date: 4 October 2018
Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?
Mohareri M, Mirhosseini A, Mehraban S, Fazeli B
Vascular Health and Risk Management 2018, 14:247-251
Published Date: 28 September 2018
Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
Fernet M, Beckerman B, Abreu P, Lins K, Vincent J, Burgess E
Vascular Health and Risk Management 2018, 14:233-246
Published Date: 20 September 2018
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T
Vascular Health and Risk Management 2018, 14:225-232
Published Date: 18 September 2018
Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents
Aflyatumova GN, Nigmatullina R, Sadykova DI, Chibireva MD, Fugetto F, Serra R
Vascular Health and Risk Management 2018, 14:213-223
Published Date: 18 September 2018
Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study
Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA
Vascular Health and Risk Management 2018, 14:205-211
Published Date: 10 September 2018
Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana
Antwi-Boasiako C, Campbell AD
Vascular Health and Risk Management 2018, 14:199-204
Published Date: 6 September 2018
Clinical accuracy of the Omron M3 Comfort® and the Omron Evolv® for self-blood pressure measurements in pregnancy and pre-eclampsia – validation according to the Universal Standard Protocol
Topouchian J, Hakobyan Z, Asmar J, Gurgenian S, Zelveian P, Asmar R
Vascular Health and Risk Management 2018, 14:189-197
Published Date: 31 August 2018
Prognosis of patients with pulmonary embolism after rehabilitation
Amoury M, Noack F, Kleeberg K, Stoevesandt D, Lehnigk B, Bethge S, Heinze V, Schlitt A
Vascular Health and Risk Management 2018, 14:183-187
Published Date: 30 August 2018
Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies
Chowdhury MZI, Haque MA, Farhana Z, Anik AM, Chowdhury AH, Haque SM, Marjana LLW, Bristi PD, Mamun BAA, Uddin MJ, Fatema J, Rahman MM, Akter T, Tani TA, Turin TC
Vascular Health and Risk Management 2018, 14:165-181
Published Date: 21 August 2018
Risk factors for deep vein thrombosis of lower extremities in Sudanese women
Ibrahim NA, Hassan FM, Elgari MM, Abdalla SE
Vascular Health and Risk Management 2018, 14:157-164
Published Date: 20 August 2018
Spontaneous internal jugular vein thrombosis as primary presentation of antiphospholipid syndrome: case report
Al-Zoubi NA
Vascular Health and Risk Management 2018, 14:153-155
Published Date: 16 July 2018
Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness
Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA
Vascular Health and Risk Management 2018, 14:145-152
Published Date: 9 July 2018
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance
Shunmoogam N, Naidoo P, Chilton R
Vascular Health and Risk Management 2018, 14:137-143
Published Date: 18 June 2018
Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
Kim SH, Patel N, Thapar K, Pandurangadu AV, Bahl A
Vascular Health and Risk Management 2018, 14:129-135
Published Date: 12 June 2018
The association between the serum level of vitamin D and ischemic heart disease: a study from Jordan
Jarrah MI, Mhaidat NM, Alzoubi KH, Alrabadi N, Alsatari E, Khader Y, Bataineh MF
Vascular Health and Risk Management 2018, 14:119-127
Published Date: 12 June 2018
Anemia and acute coronary syndrome: current perspectives
Stucchi M, Cantoni S, Piccinelli E, Savonitto S, Morici N
Vascular Health and Risk Management 2018, 14:109-118
Published Date: 30 May 2018
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L
Vascular Health and Risk Management 2018, 14:103-108
Published Date: 29 May 2018
Nonadherence to statins: individualized intervention strategies outside the pill box
Lansberg P, Lee A, Lee ZV, Subramaniam K, Setia S
Vascular Health and Risk Management 2018, 14:91-102
Published Date: 24 May 2018
Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada
Senay A, Trottier M, Delisle J, Banica A, Benoit B, Laflamme GY, Malo M, Nguyen H, Ranger P, Fernandes JC
Vascular Health and Risk Management 2018, 14:81-89
Published Date: 8 May 2018
Age–gender distribution of coronary artery calcium score in a black African population in Ghana
Asafu Adjaye Frimpong G, Owusu IK, Anyitey-Kokor IC, Wiafe-Kwakye CSNS, Aboagye E, Coleman NE, Amankwah P, Abaidoo NK
Vascular Health and Risk Management 2018, 14:75-80
Published Date: 4 May 2018
Critical limb ischemia: current challenges and future prospects
Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R
Vascular Health and Risk Management 2018, 14:63-74
Published Date: 26 April 2018
Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity
Ato D
Vascular Health and Risk Management 2018, 14:41-62
Published Date: 3 April 2018
Patient knowledge on stroke risk factors, symptoms and treatment options
Faiz KW, Sundseth A, Thommessen B, Rønning OM
Vascular Health and Risk Management 2018, 14:37-40
Published Date: 7 February 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease
Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP
Vascular Health and Risk Management 2018, 14:23-36
Published Date: 5 February 2018
Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice
Vimalesvaran K, Dockrill SJ, Gorog DA
Vascular Health and Risk Management 2018, 14:13-21
Published Date: 9 January 2018
Postural tachycardia syndrome: current perspectives
Wells R, Spurrier AJ, Linz D, Gallagher C, Mahajan R, Sanders P, Page A, Lau DH
Vascular Health and Risk Management 2018, 14:1-11
Published Date: 29 December 2017